1. Home
  2. EDIT vs ELMT Comparison

EDIT vs ELMT Comparison

Compare EDIT & ELMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Editas Medicine Inc.

EDIT

Editas Medicine Inc.

N/A

Current Price

$1.63

Market Cap

422.3M

Sector

Health Care

ML Signal

N/A

Logo The Elmet Group Co. Common Stock

ELMT

The Elmet Group Co. Common Stock

N/A

Current Price

$17.93

Market Cap

474.9M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
EDIT
ELMT
Founded
2013
1929
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
422.3M
474.9M
IPO Year
2016
2026

Fundamental Metrics

Financial Performance
Metric
EDIT
ELMT
Price
$1.63
$17.93
Analyst Decision
Buy
Strong Buy
Analyst Count
13
4
Target Price
$6.10
★ $29.00
AVG Volume (30 Days)
★ 2.2M
464.9K
Earning Date
11-09-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 37.50
N/A
EPS
N/A
★ 0.10
Revenue
★ $31,937,000.00
N/A
Revenue This Year
N/A
$34.89
Revenue Next Year
N/A
$29.22
P/E Ratio
★ N/A
$195.40
Revenue Growth
★ 132.64
N/A
52 Week Low
$1.66
$12.49
52 Week High
$3.94
$25.46

Technical Indicators

Market Signals
Indicator
EDIT
ELMT
Relative Strength Index (RSI) 29.08 42.81
Support Level N/A $17.53
Resistance Level $3.00 $21.38
Average True Range (ATR) 0.21 2.15
MACD -0.09 -0.25
Stochastic Oscillator 1.10 16.93

Price Performance

Historical Comparison
EDIT
ELMT

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.

About ELMT The Elmet Group Co. Common Stock

The Elmet Group Co provides precision-engineered components and high-energy systems for the Aerospace, Defense and Government, Industrial, Medical, Semiconductor and Electronics, and Energy industries. The company is organized into two business divisions, Critical Materials Components and Engineered Microwave Products, offering a platform with expertise across interconnected markets. The company operates an integrated engineering-to-production system, covering custom design, development, and processing across Critical Materials and High-Power Microwave. Its Engineered Microwave capabilities helps to deliver tailored microwave energy solutions, while its Critical Materials expertise allows to design reliable solutions for some of the demanding environments in the world.

Share on Social Networks: